Efficacy of thalidomide in the treatment of myelodysplastic syndromes

Haematologica. 2002 Mar;87(3):ELT18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / administration & dosage*
  • Angiogenesis Inhibitors / pharmacokinetics*
  • Female
  • Humans
  • Middle Aged
  • Myelodysplastic Syndromes / drug therapy*
  • Thalidomide / administration & dosage*
  • Thalidomide / pharmacokinetics*
  • Therapeutic Equivalency

Substances

  • Angiogenesis Inhibitors
  • Thalidomide